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Abstract
The optimal use of stress testing after coronary revascularization remains unclear, and over-
utilization of stress testing may increase rates of repeat revascularization. We analyzed the
relationship at both the patient and regional level between the use of stress testing and repeat
revascularization for a cohort of Medicare beneficiaries receiving revascularization within 30 days
of an admission for symptomatic coronary artery disease (CAD).The sample consisted of 219,748
Medicare beneficiaries older than 65 years who received percutaneous coronary intervention (PCI)
or cardiac bypass surgery (CABG) following hospital admission for symptomatic CAD in 2003–
2004. Medicare claims data through 2008 identified the use of stress testing and repeat
revascularization. Associations between the cumulative incidence of stress testing and repeat
revascularization were analyzed using linear regressions. Within six years of initial
revascularization, the cumulative incidence of events was 0.61 for stress testing and 0.23 for
repeat revascularization. Most (53.1%) repeat revascularizations were preceded by a stress test.
Only 10.3% of repeat revascularization procedures were preceded by myocardial infarction. Four-
year cumulative incidence of repeat revascularization and stress testing varied between the
Hospital Referral Regions represented by the sample, and the positive correlation between the
rates by HRR accounted for only a small portion of the total HRR variation in revascularization
rates. Stress testing is commonly performed among Medicare patients after initial
revascularization, and the majority of repeat procedures are performed for stable CAD. Variation
in stress testing patterns only explains a modest fraction of regional variation in repeat
revascularization rates.
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Although routine stress testing for patients with asymptomatic coronary artery disease
(CAD) has been advocated for patients after PCI or CABG, current Appropriateness Criteria
suggest that stress testing within 5 years of CABG or within 2 years of PCI is not
appropriate in asymptomatic patients.1 In addition, current guidelines suggest that coronary
revascularization should not be undertaken in asymptomatic patients unless there is evidence
of high risk ischemia by non-invasive imaging. Despite these guidelines, geographic
variation in use of stress testing by physicians may be associated with higher rates of repeat
revascularization given the potentially discretionary nature of both decisions. To evaluate
the contribution of regional variation in stress imaging utilization to the incidence of repeat
revascularization, we conducted a retrospective cohort review of Medicare enrollees who
underwent multivessel revascularization after admission for acute coronary syndrome.
Methods
The 2003 and 2004 Medicare Provider Analysis and Review (MedPAR) records were used
to identify all fee-for-service Medicare beneficiaries aged 66 and older admitted for
symptomatic CAD between January 1, 2003 and October 14, 2004, defined by the presence
of International Classification of Diseases, Ninth Edition, Clinical Modification (ICD-9)
diagnosis codes 410.xx, 411.1 and 413.9. Each patient’s first CAD-related hospitalization
during 2003 and 2004 was considered their index admission. For identified patients, we
obtained MedPAR, Carrier, and Outpatient Medicare claims as well as the Medicare
Denominator file for calendar years 2002 through 2008; as a result, up to six years of
follow-up were available. Using claims from the 12 months preceding the index admission
as well as the index admission itself, patients were excluded if they had a prior history of
CAD-related admission, cardiac surgery, or percutaneous coronary intervention (PCI).
MedPAR and Carrier records were used to determine whether each identified patient
received coronary revascularization during the 30 days following their index admission date
based on ICD-9 procedure codes, Healthcare Common Procedure Coding System (HCPCS)
codes, and Diagnosis-Related Groups (PCI: 36.01–36.07, 92980–92981, 92984, 92995–
92996, G0290–G0291, 516–518, 526–527, 555–558; CABG: 36.10–36.19, 33510–33523,
33530–33536, 106–107, 109, 547–550). Patients were included if their initial coronary
revascularization procedure was a multivessel PCI or CABG. We also identified and
included patients who received a staged PCI procedure by adding those patients who
received a second PCI procedure within 30 days of their first, but for which the second PCI
claim did not include an ACS-specific diagnosis code.
Carrier, Outpatient, and MedPAR records were next used to identify utilization of stress
testing following revascularization using HCPCS and ICD-9 codes (stress testing with
electrocardiogram (ECG): 93015–93018, 89.41–89.43; nuclear testing: 78460–78461,
78464–78466, 78468–78469, 78472–78473, 78481, 78483, 78491–78492, 78494, 89.44;
echocardiography: 93350). ECG stress testing and nuclear stress testing claims occurring
within 3 days of each other were considered a single, nuclear stress test; ECG stress testing
and stress echocardiography testing occurring within 24 hours of each other were considered
a single, echocardiography stress test.2 Because stress testing immediately subsequent to
revascularization may be done to assess appropriateness for cardiac rehabilitation or to
measure response to revascularization, stress tests were only included if they occurred more
than 60 days from the date of the patient’s first revascularization. Patients were included in
the analyses if they survived 60 days subsequent to their initial revascularization procedure
without repeat revascularization (with the exception of the staged PCI patients previously
described) or readmission for myocardial infarction.
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The time to stress testing and time to repeat revascularization within 6 years of the initial
revascularization were calculated using cumulative incidence techniques. Unadjusted
cumulative incidence rates of repeat revascularization were examined both across the entire
cohort and stratified by initial revascularization modality (CABG or PCI), with comparisons
of cumulative incidence made using a non-parametric test of equality.3 Finally, patients
were assigned to their Health Referral Region (HRR) from the Dartmouth Atlas based on the
zip code on their index admission MedPAR record. Using observations aggregated at the
HRR level, the correlation between the HRR-level cumulative incidence of repeat
revascularization and stress testing was assessed using simple linear regression models
weighted based on the number of cohort members in the HRR. The correlation between
HRR-level incidence of stress testing, and the proportion of patients receiving a stress test
who underwent repeat revascularization within 60 days of their stress test (the “test yield”)
was also compared using weighted linear regression.
Inferential statistics were considered significant at a two-sided alpha level of 0.05. All
calculations were conducted in Stata/MP 12.0 (Statacorp, College Station, TX) except for
competing risk calculations, which were performed in the R 2.12.1 (R Foundation, Vienna,
Austria) using the cmprsk package. The University of North Carolina Public Health-Nursing
Institutional Review Board reviewed and approved the study protocol and a waiver of
informed consent.
Results
In total 86,132 patients met inclusion criteria, of which 54,124 were treated initially with
CABG and 32,008 with PCI. Patients were followed for a mean of 1,639 days after
revascularization (standard deviation 508 days). Baseline characteristics are reported in
Table 1.
The cumulative incidence of having at least one repeat coronary revascularization procedure
more than 60 days after the initial ACS-related revascularization was 0.17. The cumulative
incidence of repeat revascularization was higher (0.28) among PCI patients at 6 years of
follow-up compared to 0.10 among CABG patients (Figure 1A; p < 0.001). Coded
indications for repeat revascularization were similar, regardless of the patient’s initial
revascularization modality (Table 2).
Using patient observations aggregated to the HRR, the cumulative incidence at 48 months
after initial revascularization varied for both stress testing (median 0.55, interquartile range
[0.48 – 0.62]) and repeat revascularization (median 0.13, interquartile range [0.11 – 0.16])
(Figures 2A and 2B). Simple linear regressions showed that the proportion of patients in an
HRR whose stress test was followed by a repeat revascularization with 60 days declined as
the cumulative incidence of testing increased. (The overall regression coefficient was −0.08,
p < 0.001, with coefficients of −0.09 and −0.06 for PCI and CABG, respectively; p < 0.001
for both. Full regression results are available on request from the authors.) Using linear
regression weighted for the number of patients in each HRR, the HRR-level cumulative
incidence of stress testing and repeat revascularization were positively and significantly
associated at both 24 and 48 months following the initial revascularization, though the
magnitude of the association was very modest (Table 3). For example, an increase in the
cumulative incidence of stress testing of 0.1 at 48 months (roughly a 20% increase at the
median) was only associated with an increase in the cumulative incidence or repeat
revascularization of 0.0058 at 48 months (roughly only a 5% increase at the median).
Furthermore, most of the association was attributable to CABG recipients, as stratification
by initial revascularization modality showed that the association remained statistically
significant for CABG, but not for PCI.
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Despite the high risk features of this population (Medicare patients with symptomatic
coronary artery disease receiving multivessel revascularization), only 10.3% of repeat
revascularization procedures were performed for patients presenting with myocardial
infarction. The majority of procedures were performed for symptoms of angina or following
a stress imaging study. These findings suggest that a large percentage repeat
revascularization procedures are dependent on the evaluation of patients with stable
coronary artery disease.
Higher rates of stress testing may contribute to higher rates of repeat revascularization
among patients with stable symptoms. The unadjusted rates of repeat revascularization were
particularly high among patients referred for PCI after initial presentation with acute
coronary syndromes. However, the relative weakness of the regional association between
stress imaging and repeat revascularization suggests that multiple factors are likely to
contribute to repeat revascularization rates, including the mode of initial revascularization
(PCI or CABG). We presented unadjusted comparisons because of the inability in this
observational dataset to adjust for the many important but unobserved clinical factors that
contribute to treatment decisions. The findings, however, are consistent with previous
studies suggesting that CABG provides improved freedom from repeat revascularization
procedures.
As the rate of stress testing increases, there is a decrease in the proportion of patients
undergoing repeat revascularization (regression coefficient −0.08, p<0.001). This result
reflects a decrease in the yield of stress testing among regions with the highest testing rates.
Shah et al. recently reported higher rates of stress testing after revascularization among
patients whose physicians billed for both technical and professional fees for the procedure.4
The presence of physician-owned imaging equipment may have contributed to the variation
in testing rates noted in this analysis.
Although we found variation in the utilization of both stress imaging and repeat coronary
revascularization, the correlation of these two events was very modest. Unfortunately, socio-
demographic and clinical data are not captured completely in Medicare claims. For instance,
we were unable to determine the frequency of smoking within our cohort, and data regarding
the location and severity of coronary lesions were also not available. In addition, variations
in socioeconomic variables that may affect access to diagnostic testing are not accounted for
in this analysis. Variation in unobserved procedural factors such as the use of arterial bypass
conduits or the use of drug eluting stents may also affect revascularization rates. Although
the use of Hospital Referral Regions was chosen in order to group the cohort according to
geographic relevance to a tertiary care center, there is likely to be significant variation in
practice patterns among hospitals and physicians within each region, and provider-level
variation in stress testing rates was not explored.
The description of regional variation in practice patterns is important, because greater
variation implies lack of a uniform standard of care. The utilization of stress imaging studies
is largely dependent on provider-level practice patterns, and higher rates of testing do not
appear to strongly predict higher rates of repeat revascularization, and therefore it must be
considered that many of these tests are not necessary. Due to concerns regarding the
utilization of diagnostic testing, the American College of Cardiology Foundation (ACCF)
has released Appropriateness Criteria to serve as a guide for clinicians when determining the
utility of these testing modalities for specific patient complaints and conditions.1, 5 While
the use of stress testing has decreased recently,6 the rate could increase in the future since
the Centers for Medicare & Medicaid Services has initiated a program to conduct audits for
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appropriateness of procedures including revascularization (www.cms.gov/apps/media/press/
factsheet.asp?Counter=4170). Although additional analysis is needed to evaluate the
ongoing utilization of stress imaging studies in the Medicare population, our findings
suggest that administrative data provide important insights into practice patterns, use of
stress testing, and clinical outcomes.
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Patient-level cumulative incidence of (A) repeat coronary revascularization and (B) stress
testing, stratified by initial revascularization modality.
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Histogram of HRR-level cumulative incidence in (A) repeat coronary revascularization and
(B) stress testing, both at 48 months after initial revascularization.
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Scatter plot illustrating correlation between HRR-level cumulative incidence of repeat
revascularization and stress testing
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Table 1








Mean Age (years) 75.0 75.8 74.5 < 0.001
Men 60.3% 53.6% 64.2% < 0.001
Diabetes Mellitus 25.7% 24.9% 26.3% < 0.001
Hypertension, with complications 50.3% 52.1% 49.3% < 0.001
Heart Failure 6.4% 8.4% 5.3% < 0.001
Prior Stroke 7.2% 6.9% 7.4% 0.03
Chronic Kidney Disease/renal failure 1.6% 1.8% 1.5% 0.002
Chronic Obstructive Pulmonary Disease 10.2% 12.2% 9.0% < 0.001
STEMI at presentation 19.0% 21.9% 17.2% < 0.001
PCI = percutaneous coronary intervention, CABG = coronary artery bypass grafting, STEMI = ST-Elevation Myocardial Infarction.
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Table 2
Coded indications for repeat revascularization, and percentage of patients whose repeat revascularization was










Angina 411.1, 413.x 37.7% 38.1% 37.0% 0.19
Other Chest pain 786.50, 786.51, 786.59 10.5% 10.6% 10.4% 0.69
AMI 410.x1 10.3% 10.6% 9.8% 0.15
Preceded by stress test within 60 days of revascularization 43.2% 41.1% 46.7% < 0.001
PCI = percutaneous coronary intervention, CABG = coronary artery bypass grafting, AMI= acute myocardial infarction.
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Table 3
Association between stress testing and repeat revascularization by Hospital Referral Region
Variable N Regression Coefficient (CI) P-value
24 Months Post Revascularization
Overall 297 0.048 (0.012, 0.084) 0.01
Percutaneous Coronary Intervention 297 0.005 (−0.057, 0.067) 0.87
Coronary Bypass Surgery 297 0.033 (0.009, 0.056) 0.01
48 Months Post Revascularization
Overall 297 0.058 (0.010, 0.107) 0.02
Percutaneous Coronary Intervention 297 0.002 (−0.077, 0.081) 0.95
Coronary Bypass Surgery 297 0.041 (0.006, 0.76) 0.02
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